Literature DB >> 29276551

Gold Nanoparticles as a Probe for Amyloid-β Oligomer and Amyloid Formation.

Esmail A Elbassal1, Clifford Morris1, Thomas W Kent1, Richard Lantz1, Bimlesh Ojha1, Ewa P Wojcikiewicz2, Deguo Du1.   

Abstract

The process of amyloid-β (Aβ) amyloid formation is pathologically linked to Alzheimer's disease (AD). The identification of Aβ amyloids and intermediates that are crucial players in the pathology of AD is critical for exploring the underlying mechanism of Aβ aggregation and the diagnosis of the disease. Herein, we performed a gold nanoparticle (AuNP)-based study to detect the formation of Aβ amyloid fibrils and oligomers. Our results demonstrate that the intensity of the surface plasmon resonance (SPR) absorption band of the AuNPs is sensitive to the quantity of Aβ40 amyloids. This allows the SPR assay to be used for detection and semi-quantification of Aβ40 amyloids, and characterization of the kinetics of Aβ amyloid formation. Furthermore, our study demonstrates that the SPR band intensity of the AuNPs is sensitive to the presence of oligomers of both Aβ40 and an Aβ40 mutant, which forms more stable oligomers. The kinetics of the stable oligomer formation of the Aβ40 mutant can also be monitored following the SPR band intensity change of AuNPs. Our results indicate that this nanoparticle based method can be used for mechanistic studies of early protein self-assembly and fibrillogenesis.

Entities:  

Year:  2017        PMID: 29276551      PMCID: PMC5737797          DOI: 10.1021/acs.jpcc.7b05169

Source DB:  PubMed          Journal:  J Phys Chem C Nanomater Interfaces        ISSN: 1932-7447            Impact factor:   4.126


  56 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

Review 2.  Synthesis and optical properties of silver nanoparticles and arrays.

Authors:  David D Evanoff; George Chumanov
Journal:  Chemphyschem       Date:  2005-07-11       Impact factor: 3.102

3.  Nanoparticles as catalysts for protein fibrillation.

Authors:  Vicki L Colvin; Kristen M Kulinowski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

4.  Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties.

Authors:  S Kumar; J Aaron; K Sokolov
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

5.  Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ.

Authors:  Kanchan Garai; Carl Frieden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Authors:  Trey Sunderland; Gary Linker; Nadeem Mirza; Karen T Putnam; David L Friedman; Lida H Kimmel; Judy Bergeson; Guy J Manetti; Matthew Zimmermann; Brian Tang; John J Bartko; Robert M Cohen
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

8.  Cancer cell targeting using multiple aptamers conjugated on nanorods.

Authors:  Yu-Fen Huang; Huan-Tsung Chang; Weihong Tan
Journal:  Anal Chem       Date:  2008-01-01       Impact factor: 6.986

Review 9.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

10.  Nucleation of protein fibrillation by nanoparticles.

Authors:  Sara Linse; Celia Cabaleiro-Lago; Wei-Feng Xue; Iseult Lynch; Stina Lindman; Eva Thulin; Sheena E Radford; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

View more
  12 in total

1.  N-Terminal Charged Residues of Amyloid-β Peptide Modulate Amyloidogenesis and Interaction with Lipid Membrane.

Authors:  Clifford Morris; Shirin Cupples; Thomas W Kent; Esmail A Elbassal; Ewa P Wojcikiewicz; Peng Yi; Deguo Du
Journal:  Chemistry       Date:  2018-06-06       Impact factor: 5.236

2.  Improving Sensitivity and Specificity of Amyloid-β Peptides and Tau Protein Detection with Antibiofouling Magnetic Nanoparticles for Liquid Biopsy of Alzheimer's Disease.

Authors:  Yuancheng Li; Esther Lim; Travis Fields; Hui Wu; Yaolin Xu; Y Andrew Wang; Hui Mao
Journal:  ACS Biomater Sci Eng       Date:  2019-06-10

Review 3.  Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review.

Authors:  Jonathan Pansieri; Matthieu Gerstenmayer; François Lux; Sebastien Mériaux; Olivier Tillement; Vincent Forge; Benoit Larrat; Christel Marquette
Journal:  Nanomaterials (Basel)       Date:  2018-09-18       Impact factor: 5.076

4.  Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism.

Authors:  Christine Xue; Joyce Tran; Hongsu Wang; Giovanna Park; Frederick Hsu; Zhefeng Guo
Journal:  R Soc Open Sci       Date:  2019-07-10       Impact factor: 2.963

5.  Mucin-Type O-Glycosylation Proximal to β-Secretase Cleavage Site Affects APP Processing and Aggregation Fate.

Authors:  YashoNandini Singh; Deepika Regmi; David Ormaza; Ramya Ayyalasomayajula; Nancy Vela; Gustavo Mundim; Deguo Du; Dmitriy Minond; Maré Cudic
Journal:  Front Chem       Date:  2022-04-08       Impact factor: 5.545

6.  Electrochemiluminescence of gold nanoparticles and gold nanoparticle-labelled antibodies as co-reactants.

Authors:  Changzhi Zhao; Lulu Niu; Xiaoyu Wang; Wei Sun
Journal:  RSC Adv       Date:  2018-10-24       Impact factor: 4.036

Review 7.  Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.

Authors:  Hitesh Chopra; Shabana Bibi; Inderbir Singh; Mohammad Amjad Kamal; Fahadul Islam; Fahad A Alhumaydhi; Talha Bin Emran; Simona Cavalu
Journal:  Front Aging Neurosci       Date:  2022-07-08       Impact factor: 5.702

Review 8.  Research Models of the Nanoparticle-Mediated Drug Delivery across the Blood-Brain Barrier.

Authors:  Quan-You Li; Jung-Hwan Lee; Hae-Won Kim; Guang-Zhen Jin
Journal:  Tissue Eng Regen Med       Date:  2021-06-28       Impact factor: 4.451

Review 9.  Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer's Disease.

Authors:  María Paz Oyarzún; Andreas Tapia-Arellano; Pablo Cabrera; Pedro Jara-Guajardo; Marcelo J Kogan
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

Review 10.  Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer's Patients.

Authors:  Mohamed Abbas
Journal:  Polymers (Basel)       Date:  2021-03-27       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.